Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Se-Jin Lee, myostatin discoverer, elected to the National Academy of Science.

Glass DJ, Spiegelman BM.

Skelet Muscle. 2012 Jun 7;2(1):11. doi: 10.1186/2044-5040-2-11.

2.

Gene expression in sexually dimorphic muscles in sheep.

Mateescu RG, Thonney ML.

J Anim Sci. 2002 Jul;80(7):1879-87.

3.

The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.

Matsakas A, Diel P.

Int J Sports Med. 2005 Mar;26(2):83-9. Review.

PMID:
15726494
4.

Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration.

Zachwieja JJ, Smith SR, Sinha-Hikim I, Gonzalez-Cadavid N, Bhasin S.

J Gravit Physiol. 1999 Oct;6(2):11-5.

PMID:
11543081
5.

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.

Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM.

Biochem Biophys Res Commun. 2003 Jan 24;300(4):965-71.

PMID:
12559968
7.

Regulation of myostatin activity and muscle growth.

Lee SJ, McPherron AC.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9306-11. Epub 2001 Jul 17.

8.

[Therapeutic strategies for muscular dystrophy by myostatin inhibition].

Sunada Y.

Rinsho Shinkeigaku. 2006 Nov;46(11):942-4. Japanese.

PMID:
17432227
9.

Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis.

Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J.

J Biol Chem. 2007 Aug 31;282(35):25852-63. Epub 2007 Jun 27.

10.

Myostatin expression and possible functions in animal muscle growth.

Kocamis H, Killefer J.

Domest Anim Endocrinol. 2002 Nov;23(4):447-54. Review.

PMID:
12457953
11.

The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.

Patel K, Amthor H.

Neuromuscul Disord. 2005 Feb;15(2):117-26. Epub 2005 Jan 11. Review.

PMID:
15694133
12.

Myostatin: a modulator of skeletal-muscle stem cells.

Walsh FS, Celeste AJ.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1513-7. Review.

PMID:
16246158
13.

Myostatin: a therapeutic target for skeletal muscle wasting.

Roth SM, Walsh S.

Curr Opin Clin Nutr Metab Care. 2004 May;7(3):259-63. Review.

PMID:
15075916
14.

Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice.

Miyake M, Hayashi S, Sato T, Taketa Y, Watanabe K, Hayashi S, Tanaka S, Ohwada S, Aso H, Yamaguchi T.

Cell Biol Int. 2007 Oct;31(10):1274-9. Epub 2007 May 21.

PMID:
17590360
15.

The myostatin gene: physiology and pharmacological relevance.

Joulia-Ekaza D, Cabello G.

Curr Opin Pharmacol. 2007 Jun;7(3):310-5. Epub 2007 Mar 19. Review.

PMID:
17374508
16.

The possible role of myostatin in skeletal muscle atrophy and cachexia.

Jespersen J, Kjaer M, Schjerling P.

Scand J Med Sci Sports. 2006 Apr;16(2):74-82. Review.

PMID:
16533345
17.

The therapeutic potential of agents that inactivate myostatin.

Bishop A, Kambadur R, Sharma M.

Expert Opin Investig Drugs. 2005 Sep;14(9):1099-106. Review.

PMID:
16144494
18.

Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.

Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ, Bass JJ.

J Cell Physiol. 1999 Jul;180(1):1-9.

PMID:
10362012
19.

Dominant negative myostatin produces hypertrophy without hyperplasia in muscle.

Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM.

FEBS Lett. 2000 May 26;474(1):71-5.

Supplemental Content

Support Center